126 related articles for article (PubMed ID: 38490063)
1. Novel 6-hydroxybenzothiazol-2-carboxamides as potent and selective monoamine oxidase B inhibitors endowed with neuroprotective activity.
Al-Saad OM; Gabr M; Darwish SS; Rullo M; Pisani L; Miniero DV; Liuzzi GM; Kany AM; Hirsch AKH; Abadi AH; Engel M; Catto M; Abdel-Halim M
Eur J Med Chem; 2024 Apr; 269():116266. PubMed ID: 38490063
[TBL] [Abstract][Full Text] [Related]
2. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion
Nakamura Y; Arawaka S; Sato H; Sasaki A; Shigekiyo T; Takahata K; Tsunekawa H; Kato T
J Neurosci; 2021 Sep; 41(35):7479-7491. PubMed ID: 34290084
[TBL] [Abstract][Full Text] [Related]
3. Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors.
Tzvetkov NT; Stammler HG; Neumann B; Hristova S; Antonov L; Gastreich M
Eur J Med Chem; 2017 Feb; 127():470-492. PubMed ID: 28107736
[TBL] [Abstract][Full Text] [Related]
4. Indoles and 1-(3-(benzyloxy)benzyl)piperazines: Reversible and selective monoamine oxidase B inhibitors identified by screening an in-house compound library.
Knez D; Hrast M; Frlan R; Pišlar A; Žakelj S; Kos J; Gobec S
Bioorg Chem; 2022 Feb; 119():105581. PubMed ID: 34990933
[TBL] [Abstract][Full Text] [Related]
5. The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues.
Van der Walt MM; Terre'Blanche G; Petzer A; Petzer JP
Bioorg Chem; 2015 Apr; 59():117-23. PubMed ID: 25746740
[TBL] [Abstract][Full Text] [Related]
6. Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors.
Rullo M; La Spada G; Miniero DV; Gottinger A; Catto M; Delre P; Mastromarino M; Latronico T; Marchese S; Mangiatordi GF; Binda C; Linusson A; Liuzzi GM; Pisani L
Eur J Med Chem; 2023 Jul; 255():115352. PubMed ID: 37178666
[TBL] [Abstract][Full Text] [Related]
7. Benzyloxynitrostyrene analogues - A novel class of selective and highly potent inhibitors of monoamine oxidase B.
Van der Walt MM; Terre'Blanche G; Petzer JP; Petzer A
Eur J Med Chem; 2017 Jan; 125():1193-1199. PubMed ID: 27855360
[TBL] [Abstract][Full Text] [Related]
8. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V
ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051
[TBL] [Abstract][Full Text] [Related]
9. (Hetero-)(arylidene)arylhydrazides as Multitarget-Directed Monoamine Oxidase Inhibitors.
Palakkathondi A; Oh JM; Dev S; Rangarajan TM; Kaipakasseri S; Kavully FS; Gambacorta N; Nicolotti O; Kim H; Mathew B
ACS Comb Sci; 2020 Nov; 22(11):592-599. PubMed ID: 33047950
[TBL] [Abstract][Full Text] [Related]
10. Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors.
Gaspar A; Reis J; Fonseca A; Milhazes N; Viña D; Uriarte E; Borges F
Bioorg Med Chem Lett; 2011 Jan; 21(2):707-9. PubMed ID: 21194943
[TBL] [Abstract][Full Text] [Related]
11. Novel monoamine oxidase inhibitors based on the privileged 2-imidazoline molecular framework.
Shetnev A; Osipyan A; Baykov S; Sapegin A; Chirkova Z; Korsakov M; Petzer A; Engelbrecht I; Petzer JP
Bioorg Med Chem Lett; 2019 Jan; 29(1):40-46. PubMed ID: 30455149
[TBL] [Abstract][Full Text] [Related]
12. Chemical and Biological Evaluation of Novel 1
Kulikova LN; Purgatorio R; Beloglazkin AA; Tafeenko VA; Reza RG; Levickaya DD; Sblano S; Boccarelli A; de Candia M; Catto M; Voskressensky LG; Altomare CD
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175433
[TBL] [Abstract][Full Text] [Related]
13. Dual Target Ligands with 4-
Łażewska D; Olejarz-Maciej A; Reiner D; Kaleta M; Latacz G; Zygmunt M; Doroz-Płonka A; Karcz T; Frank A; Stark H; Kieć-Kononowicz K
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32408504
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and evaluation of 3,7-substituted coumarin derivatives as multifunctional Alzheimer's disease agents.
Mzezewa SC; Omoruyi SI; Zondagh LS; Malan SF; Ekpo OE; Joubert J
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1607-1621. PubMed ID: 34281458
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of rasagiline-clorgyline hybrids as novel dual inhibitors of monoamine oxidase-B and amyloid-β aggregation against Alzheimer's disease.
Xie SS; Liu J; Tang C; Pang C; Li Q; Qin Y; Nong X; Zhang Z; Guo J; Cheng M; Tang W; Liang N; Jiang N
Eur J Med Chem; 2020 Sep; 202():112475. PubMed ID: 32652406
[TBL] [Abstract][Full Text] [Related]
16. Novel multi-target directed ligands based on annelated xanthine scaffold with aromatic substituents acting on adenosine receptor and monoamine oxidase B. Synthesis, in vitro and in silico studies.
Załuski M; Schabikowski J; Schlenk M; Olejarz-Maciej A; Kubas B; Karcz T; Kuder K; Latacz G; Zygmunt M; Synak D; Hinz S; Müller CE; Kieć-Kononowicz K
Bioorg Med Chem; 2019 Apr; 27(7):1195-1210. PubMed ID: 30808606
[TBL] [Abstract][Full Text] [Related]
17. Discovery of 3,4-dichloro-N-(1H-indol-5-yl)benzamide: A highly potent, selective, and competitive hMAO-B inhibitor with high BBB permeability profile and neuroprotective action.
Elkamhawy A; Kim HJ; Elsherbeny MH; Paik S; Park JH; Gotina L; Abdellattif MH; Gouda NA; Cho J; Lee K; Nim Pae A; Park KD; Roh EJ
Bioorg Chem; 2021 Nov; 116():105352. PubMed ID: 34562673
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 4-substituted benzyl-2-triazole-linked-tryptamine-paeonol derivatives and evaluation of their selective inhibitions against butyrylcholinesterase and monoamine oxidase-B.
Oh JM; Kang Y; Hwang JH; Park JH; Shin WH; Mun SK; Lee JU; Yee ST; Kim H
Int J Biol Macromol; 2022 Sep; 217():910-921. PubMed ID: 35908673
[TBL] [Abstract][Full Text] [Related]
19. Discovery of reversible selective monoamine oxidase B inhibitors with anti-acetylcholinesterase activity derived from 4-oxo-N-4-diphenyl butanamides.
Jana S; Nasreen T; Singh SK
Future Med Chem; 2023 Jan; 15(2):189-210. PubMed ID: 36799336
[No Abstract] [Full Text] [Related]
20. Benextramine and derivatives as novel human monoamine oxidases inhibitors: an integrated approach.
Di Paolo ML; Cozza G; Milelli A; Zonta F; Sarno S; Minniti E; Ursini F; Rosini M; Minarini A
FEBS J; 2019 Dec; 286(24):4995-5015. PubMed ID: 31291696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
